๐ฐ Scott Lim News
Scott Lim News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scott Lim. Real-time updates on events, politics, business and more.
June 6, 2024
Current transcatheter mitral valve replacement devices a poor match for clinical need
January 4, 2024
Five implants successfully accomplished at the Instituto Nacional de Torax in Santiago, Chile with advanced engineered heart valve, ZETA, designed to provide flexibility and optionality regardless of high, low or zero calcification
October 24, 2023
New heart valves, ALPHA and ZETA, designed to provide flexibility and optionality regardless of high, low or zero calcification statusPatients with aortic regurgitation achieve complete resolution of regurgitation immediately following procedure.First-in-class, Aortic Valve Systems offer self-expanding or balloon-expanding versatility based on physician preference and patient case dynamicsVersatile designs expected to significantly broaden patient eligibility for implant IRVINE, Calif., Oct. 24,
August 31, 2023
(JNS)ย โ Trisol Medical Ltd., an Israeli medical device company, has successfully implanted its Transcatheter Tricuspid Valve in two patients in
August 27, 2023
The two procedures were part of a U.S. Food and Drug Administration-approved Early Feasibility Study.The post ‘Major Milestone’: Israeli heart valve implanted in first US patients appeared first on JNS.org.
August 24, 2023
To date, the valve has been implanted in ten human subjects, five of whom were part of an Israeli pilot study.
May 2, 2023
Melanoma is the deadliest type of skin cancer. Nearly 8,000 Americans are expected to die from melanoma in 2023.
December 8, 2022
/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the companys strategy for longer-term growth, provide an update on its technology...
September 23, 2022
According to a new randomized controlled trial PASCALtranscatheter valve repair system was non-inferior compared with MitraClip in patients with significant symptomatic DMR who are not eligible for...
September 20, 2022
Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular Interventionsย